Pharma marketers are facing a new level of uncertainty around direct-to-consumer advertising in the U.S.. On July 23, 2026, the non-profit consumer rights advocacy group Public Citizen petitioned the FDA to ban direct-to-consumer advertising of prescription drugs. Just earlier that month, the FDA included a planned rule in its 2026 Unified Agenda that would eliminate the adequate-provision pathway that has helped make broadcast DTC...Read More